oral semaglutide clinical trials A trial from the University of Colorado Anschutz found semaglutide, the medication behind Ozempic and Wegovy, can reduce heavy drinking in adults with alcohol use disorder. Read more: https://www.forbes.com/sites/antoniopequenoiv/2026/07 Summary of the randomized, controlled

The study received funding from Wellcome, Medical Research Council, European Union Horizon 2020 Programme, the National Institutes of Health (grants U01-DK105535, U01-DK085545 and UM-1DK126185), the National Institute for Health Research Oxford Biomedical Research Centre, the Canadian Institutes of Health Research, the Novo Nordisk Foundation, Boehringer Ingelheim and Diabetes Australia

Talk to a licensed clinician before starting, stopping, or changing any medication

Disparities between antioxidant activity and ROS levels can lead to oxidative stress

Ingredients: L-glutachion yeast extract 30.77% (Dutch), fullerene, vitamin C, lemon juice powder [dextrin, lemon juice (100% American), arabic gum, citric acid, admixture (jujeong, purified water, natural flavoring), hydroxypropyl methylcellulose, enzyme-treated stevia, milkseed extract (American), natural extract (Clorine), vitamin E, vitamin E *Contains Milk

This includes assessment of tissue resilience, inflammatory signaling, and regenerative capacity at the cellular level